Perkins Coie advised Xentria Inc. on the deal.Xentria Inc., a clinical-stage biotherapeutics company dedicated to developing novel therapeutics to address unmet medical needs, announced its exclusive multi-year…
Xentria’s Multi-Year Licensing Agreement with Meitheal
